Morningstar Biotech: Net profit for the first quarter of 2026 was 96.72 million yuan, a year-on-year decrease of 11.65%.

Morning Light Biology announced that its operating income for the first quarter of 2026 was 1.629 billion yuan, a year-on-year decrease of 5.10%. Net profit was 96.7216 million yuan, a year-on-year decrease of 11.65%.